Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Guidant ICDs: Three deaths have now been associated with clinical failures of Guidant's Contak Renewal and Renewal 2 implantable cardioverter defibrillators that were manufactured on or before Aug. 26, 2004, according an 1Oct. 13 Preliminary Public Health Notification from FDA. The notice updates a July 14 agency communication about malfunctions with the Renewal products as well as the Ventak Prizm 2 ICDs, which led to a Class I recall (2"The Gray Sheet" June 20, 2005, p. 19). Guidant has reported a total of 49 instances of these ICDs exhibiting the specified failure mode...
You may also be interested in...
Stakeholders Argue Over Deadline For Marking Of Reprocessed Devices
Senators Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) say FDA is misinterpreting deadlines for recently enacted device marking provisions
Stakeholders Argue Over Deadline For Marking Of Reprocessed Devices
Senators Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) say FDA is misinterpreting deadlines for recently enacted device marking provisions
MDUFMA II Should Address Pre-IDE Process, Cycle Goals – Stakeholders
FDA should work to improve the process by which companies and the agency negotiate clinical trial designs, several participants argued at the third annual MDUFMA stakeholder meeting Nov. 17